T1	SectionAnnotate 136 163	HISTORY OF PRESENT ILLNESS:
T2	SectionAnnotate 2007 2028	Past Medical History:
T3	SectionSkip 2371 2383	MEDICATIONS:
T4	SectionSkip 2385 3173	Current Outpatient Prescriptions   Medication Sig Dispense Refill    ergocalciferol, vitamin D2, (ERGOCALCIFEROL) 50,000 unit capsule       metFORMIN (GLUCOPHAGE) 500 mg tablet       omega-3 fatty acids-fish oil 300-1,000 mg capsule       GAVILYTE-G 236-22.74-6.74 -5.86 gram solution       JOLIVETTE 0.35 mg tablet       ondansetron (ZOFRAN) 8 mg tablet To be taken as needed for nausea ( see colonoscopy prep instructions for details) 1 tablet 1    ondansetron (ZOFRAN) 8 mg tablet To be taken as needed for nausea ( see colonoscopy prep instructions for details) 1 tablet 1    prednisoLONE acetate (PRED FORTE) 1 % ophthalmic suspension       PROLENSA 0.07 % DROPSOLN       VIGAMOX 0.5 % ophthalmic solution        No current facility-administered medications for this visit.
T5	SectionSkip 3181 3201	ALLERGIES:  No Known
T6	SectionAnnotate 3215 3230	FAMILY HISTORY:
T7	SectionAnnotate 3232 3246	Family History
T8	SectionAnnotate 3368 3383	SOCIAL HISTORY:
T9	SectionAnnotate 3385 3399	Social History
T10	SectionAnnotate 3404 3428	Social History Narrative
T11	SectionAnnotate 3762 3779	Review of Systems
T12	SectionSkip 3854 4629	PHYSICAL EXAM:  General appearance - alert, well appearing, and in no 
 distress  HEENT: anicteric, OP clear  Mental status - alert, oriented to person, place, and time  Lymph nodes - no palpable cervical or supraclavicular lymphadenopathy   Axilla - multiple right axillary nodes, largest 2.5 cm and mobile  Breasts - 7x5 cm mass in RUOQ, mobile, inverted right nipple, left breast without dominant mass   Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm  Abdomen - soft,ND/NT, no HSM  Neurological - A&Ox3, grossly non-focal  Musculoskeletal - No point tenderness in spine or other ***** tenderness  Extremities - no edema  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
T14	SectionSkip 4633 4683	LABS:    IMAGING/PATHOLOGY:  As noted above in HPI
T17	PROBLEM 37 69	newly diagnosed HR-negative HER2
T18	PROBLEM 71 84	breast cancer
T19	TREATMENT 101 117	systemic therapy
T20	TREATMENT 122 132	management
T21	PROBLEM 204 228	3D Tomo- spiculated mass
T22	PROBLEM 284 317	adjacent architectural distortion
T23	PROBLEM 322 332	nodularity
T24	TEST 336 346	Ultrasound
T25	PROBLEM 354 365	1.6 cm mass
T26	PROBLEM 381 398	another 1 cm mass
T27	PROBLEM 403 420	0.5 adjacent mass
T28	PROBLEM 422 452	Suspicious right axillary node
T29	TEST 465 489	right breast core biopsy
T30	TEST 504 507	LVI
T31	TEST 509 515	ER-neg
T32	TEST 517 519	PR
T33	TEST 525 529	HER2
T34	TEST 534 544	FISH ratio
T35	TEST 550 554	Ki67
T36	TEST 570 591	Right axillary LN FNA
T37	PROBLEM 594 619	metastatic breast adenoca
T38	TEST 632 642	Breast MRI
T39	PROBLEM 655 683	multiple right breast masses
T40	TEST 703 707	clip
T41	PROBLEM 709 730	similar adjacent mass
T42	TEST 752 756	clip
T43	PROBLEM 758 792	Multiple additional smaller masses
T44	TEST 909 915	PET CT
T45	PROBLEM 944 973	hypermetabolism in left ilium
T46	PROBLEM 1022 1040	metastatic disease
T47	PROBLEM 1043 1060	Right breast mass
T48	PROBLEM 1072 1113	the patient's known primary breast cancer
T49	PROBLEM 1118 1169	multiple right axillary and subpectoral lymph nodes
T50	PROBLEM 1186 1207	lymph node metastases
T51	PROBLEM 1210 1272	3.4 x 2.6 cm hyperattenuating and mildly hypermetabolic lesion
T52	PROBLEM 1335 1355	a carotid body tumor
T53	TEST 1370 1373	MRI
T54	PROBLEM 1392 1428	3 rounded foci of signal abnormality
T55	PROBLEM 1433 1499	enhancement involving the left iliac bone and bilateral sacral ala
T56	PROBLEM 1539 1565	osseous metastatic disease
T57	TEST 1592 1604	MR Face/Neck
T58	PROBLEM 1608 1654	Avidly enhancing left carotid bifurcation mass
T59	PROBLEM 1660 1670	flow voids
T60	PROBLEM 1675 1738	splaying of the proximal internal and external carotid arteries
T61	TEST 1740 1767	The imaging characteristics
T62	PROBLEM 1786 1814	a carotid body paraganglioma
T63	PROBLEM 1883 1892	bone pain
T64	PROBLEM 1896 1923	any other systemic concerns
T65	PROBLEM 1934 1947	her neck mass
T66	PROBLEM 2050 2063	Breast cancer
T67	PROBLEM 2069 2086	Diabetes mellitus
T68	TREATMENT 2358 2382	HRT          MEDICATIONS
T69	TREATMENT 2385 2430	Current Outpatient Prescriptions   Medication
T70	TREATMENT 2435 2450	Dispense Refill
T71	TREATMENT 2455 2499	ergocalciferol, vitamin D2, (ERGOCALCIFEROL)
T72	TREATMENT 2527 2549	metFORMIN (GLUCOPHAGE)
T73	TREATMENT 2571 2599	omega-3 fatty acids-fish oil
T74	TREATMENT 2681 2690	JOLIVETTE
T75	TREATMENT 2713 2733	ondansetron (ZOFRAN)
T76	PROBLEM 2772 2778	nausea
T77	TREATMENT 2843 2863	ondansetron (ZOFRAN)
T78	PROBLEM 2902 2908	nausea
T79	TREATMENT 2973 3006	prednisoLONE acetate (PRED FORTE)
T80	TREATMENT 3040 3048	PROLENSA
T81	TREATMENT 3072 3079	VIGAMOX
T82	TREATMENT 3146 3157	medications
T83	PROBLEM 3196 3211	Known Allergies
T84	PROBLEM 3320 3330	malignancy
T85	TEST 3791 3808	review of systems
T86	PROBLEM 3926 3934	distress
T87	TEST 4024 4035	Lymph nodes
T88	PROBLEM 4041 4093	palpable cervical or supraclavicular lymphadenopathy
T89	PROBLEM 4105 4134	multiple right axillary nodes
T90	PROBLEM 4173 4192	7x5 cm mass in RUOQ
T91	PROBLEM 4245 4258	dominant mass
T92	TEST 4278 4290	auscultation
T93	PROBLEM 4295 4302	wheezes
T94	PROBLEM 4304 4309	rales
T95	PROBLEM 4313 4320	rhonchi
T96	PROBLEM 4395 4400	ND/NT
T97	PROBLEM 4405 4408	HSM
T98	PROBLEM 4472 4497	point tenderness in spine
T99	PROBLEM 4513 4523	tenderness
T100	PROBLEM 4542 4547	edema
T101	PROBLEM 4589 4595	rashes
T102	PROBLEM 4600 4623	suspicious skin lesions
T103	PROBLEM 4744 4776	newly diagnosed HR-negative HER2
T104	PROBLEM 4778 4791	breast cancer
T105	TREATMENT 4808 4824	systemic therapy
T106	TREATMENT 4829 4839	management
T107	TEST 4842 4852	Her PET CT
T108	PROBLEM 4871 4886	bone metastasis
T109	TEST 4900 4916	her staging work
T110	TEST 4933 4946	MRI of pelvis
T111	TEST 4951 4957	biopsy
T112	TEST 4962 4991	definitive stage IV diagnosis
T113	PROBLEM 4997 5005	stage IV
T114	TREATMENT 5020 5036	systemic therapy
T115	TREATMENT 5042 5059	weekly paclitaxel
T116	TREATMENT 5066 5077	trastuzumab
T117	TREATMENT 5084 5094	pertuzumab
T118	TREATMENT 5174 5199	long term disease control
T119	PROBLEM 5208 5220	asymptomatic
T120	PROBLEM 5226 5237	bone lesion
T121	PROBLEM 5249 5269	radiate bone lesions
T122	TEST 5290 5310	MRI Pelvis  MRI neck
T123	TREATMENT 5361 5378	weekly paclitaxel
T124	TREATMENT 5385 5396	trastuzumab
T125	TREATMENT 5403 5413	pertuzumab
T126	TEST 5424 5460	echocardiogram  Port placement  labs
T127	TREATMENT 5596 5622	Reviewed treatment options
T128	TREATMENT 5624 5646	treatment side effects
T129	TREATMENT 5814 5829	the medications
T130	PROBLEM 5834 5843	allergies
T131	Age 17 19	53
T132	BiomarkerName 53 55	HR
A1	HistoryVal T132 new
A2	EpisodeDescription T132 FirstOccurrence
T133	BiomarkerName 65 69	HER2
A3	HistoryVal T133 new
A4	EpisodeDescription T133 FirstOccurrence
T134	ClinicalCondition 71 84	breast cancer
A5	ContinuityVal T134 new
T135	BiomarkerResult 56 64	negative
A6	HistoryVal T135 new
A7	EpisodeDescription T135 FirstOccurrence
T136	BiomarkerResult 69 70	+
A8	HistoryVal T136 new
A9	EpisodeDescription T136 FirstOccurrence
A10	BiomarkerResultVal T136 Positive
R1	BiomarkerRel Arg1:T136 Arg2:T133	
R2	BiomarkerRel Arg1:T132 Arg2:T135	
R3	TumorDesc TumorDetails:T134 Desc:T133	
R4	TumorDesc TumorDetails:T134 Desc:T132	
T137	Datetime 167 175	06/09/16
T138	Radiology 193 211	mammo with 3D Tomo
A11	IntentVal T138 diagnosis
T139	Site 176 181	right
R5	SiteOf Arg1:T139 Arg2:T138	
R6	HappensAtOnDuring Arg1:T138 Arg2:T137	
T140	RadPathResult 213 228;239 245	spiculated mass 2.2 cm
A12	RadPathResultVal T140 InitialCancerDiagnosis
T141	Site 251 265;272 278	10-11:00    in breast
T142	Laterality 266 271	right
R7	LateralityOfSite Arg1:T142 Arg2:T141	
R8	SiteOf Arg1:T141 Arg2:T140	
R9	ResultOfTest Desc:T140 Test:T138	
T143	Radiology 336 346	Ultrasound
A13	IntentVal T143 diagnosis
T144	RadPathResult 354 365	1.6 cm mass
A14	RadPathResultVal T144 InitialCancerDiagnosis
R10	ResultOfTest Desc:T144 Test:T143	
T145	Site 369 374	10:00
R11	SiteOf Arg1:T145 Arg2:T144	
T146	RadPathResult 389 398	1 cm mass
A15	RadPathResultVal T146 InitialCancerDiagnosis
T147	RadPathResult 403 406;416 420	0.5 mass
A16	RadPathResultVal T147 InitialCancerDiagnosis
R12	ResultOfTest Desc:T146 Test:T143	
R13	ResultOfTest Desc:T147 Test:T143	
T148	Datetime 456 464	06/30/16
T149	Pathology 478 489	core biopsy
A17	IntentVal T149 diagnosis
T150	Site 471 477	breast
T151	Laterality 465 470	right
R14	LateralityOfSite Arg1:T151 Arg2:T150	
R15	SiteOf Arg1:T150 Arg2:T149	
R16	HappensAtOnDuring Arg1:T149 Arg2:T148	
T152	Histology 492 495	IDC
A18	HistoryVal T152 new
A19	EpisodeDescription T152 FirstOccurrence
R17	TestOrProcedureReveals Test:T149 Desc:T152	
T153	LocalInvasion 504 507	LVI
A20	NegationModalityVal T153 negated
A21	HistoryVal T153 new
A22	EpisodeDescription T153 FirstOccurrence
T154	BiomarkerName 509 511	ER
A23	HistoryVal T154 new
A24	EpisodeDescription T154 FirstOccurrence
T155	BiomarkerName 517 519	PR
A25	HistoryVal T155 new
A26	EpisodeDescription T155 FirstOccurrence
T156	BiomarkerName 525 529	HER2
A27	HistoryVal T156 new
A28	EpisodeDescription T156 FirstOccurrence
T157	Pathology 534 538	FISH
A29	IntentVal T157 diagnosis
T158	BiomarkerResult 512 515	neg
A30	HistoryVal T158 new
A31	EpisodeDescription T158 FirstOccurrence
T159	BiomarkerResult 520 523	neg
A32	HistoryVal T159 new
A33	EpisodeDescription T159 FirstOccurrence
A34	BiomarkerResultVal T159 Negative
T160	BiomarkerResult 531 532	+
A35	HistoryVal T160 new
A36	EpisodeDescription T160 FirstOccurrence
A37	BiomarkerResultVal T160 Positive
R18	BiomarkerRel Arg1:T160 Arg2:T156	
R19	BiomarkerRel Arg1:T159 Arg2:T155	
R20	BiomarkerRel Arg1:T154 Arg2:T158	
T161	RadPathResult 545 547	13
R21	ResultOfTest Desc:T161 Test:T157	
T162	Pathology 550 554	Ki67
A38	IntentVal T162 diagnosis
T163	RadPathResult 555 561	10-15%
R22	ResultOfTest Desc:T163 Test:T162	
T164	Pathology 588 591	FNA
T165	Site 576 587	axillary LN
T166	Laterality 570 575	Right
R23	LateralityOfSite Arg1:T166 Arg2:T165	
R24	SiteOf Arg1:T165 Arg2:T164	
T167	Histology 612 619	adenoca
A39	HistoryVal T167 new
A40	EpisodeDescription T167 FirstOccurrence
T168	Site 605 611	breast
T169	Metastasis 594 604	metastatic
A41	HistoryVal T169 new
A42	EpisodeDescription T169 FirstOccurrence
R25	TestOrProcedureReveals Test:T149 Desc:T153	
R26	TestOrProcedureReveals Test:T149 Desc:T154	
R27	TestOrProcedureReveals Test:T149 Desc:T155	
R28	TestOrProcedureReveals Test:T149 Desc:T156	
R29	TestOrProcedureReveals Test:T164 Desc:T169	
R30	TestOrProcedureReveals Test:T164 Desc:T167	
R31	SiteOf Arg1:T168 Arg2:T167	
T170	Datetime 623 631	07/22/16
T171	Pathology 639 642	MRI
A43	IntentVal T171 diagnosis
T172	Site 632 638	Breast
T173	Laterality 647 652	RIGHT
R32	SiteOf Arg1:T172 Arg2:T171	
R33	LateralityOfSite Arg1:T173 Arg2:T172	
T174	RadPathResult 655 663;677 683	multiple masses
A44	RadPathResultVal T174 InitialCancerDiagnosis
T175	Site 670 676	breast
T176	Laterality 664 669	right
R34	LateralityOfSite Arg1:T176 Arg2:T175	
R35	SiteOf Arg1:T175 Arg2:T174	
R36	ResultOfTest Desc:T174 Test:T171	
T177	Size 685 697	2.4 x 1.7 cm
A45	HistoryVal T177 new
A46	EpisodeDescription T177 FirstOccurrence
T178	Size 731 741	2.4x1.6 cm
A47	HistoryVal T178 new
A48	EpisodeDescription T178 FirstOccurrence
T179	LymphNodeInvolvement 832 835	LNs
A49	HistoryVal T179 new
A50	EpisodeDescription T179 FirstOccurrence
T180	Site 823 831	axillary
R37	SiteOf Arg1:T180 Arg2:T179	
T181	Datetime 900 908	07/24/16
T182	Radiology 909 915	PET CT
A51	IntentVal T182 staging
T183	Metastasis 1022 1032	metastatic
A52	NegationModalityVal T183 uncertain_in_present
A53	HistoryVal T183 new
A54	EpisodeDescription T183 FirstOccurrence
R39	HappensAtOnDuring Arg1:T182 Arg2:T181	
R40	TestOrProcedureReveals Test:T182 Desc:T183	
T185	Datetime 1361 1369	07/31/16
T186	Radiology 1370 1373	MRI
A55	IntentVal T186 staging
T187	Site 1374 1380	Pelvis
R41	SiteOf Arg1:T187 Arg2:T186	
R42	HappensAtOnDuring Arg1:T186 Arg2:T185	
T188	Metastasis 1547 1557	metastatic
A56	NegationModalityVal T188 uncertain_in_present
A57	HistoryVal T188 new
A58	EpisodeDescription T188 FirstOccurrence
T189	Site 1539 1546	osseous
R43	SiteOf Arg1:T189 Arg2:T188	
R44	TestOrProcedureReveals Test:T186 Desc:T188	
T191	Pathology 1592 1594	MR
A59	IntentVal T191 staging
T192	Site 1595 1604	Face/Neck
R46	SiteOf Arg1:T192 Arg2:T191	
T193	Datetime 1573 1590	*****/*****/*****
R47	HappensAtOnDuring Arg1:T191 Arg2:T193	
T194	RadPathResult 1788 1814	carotid body paraganglioma
A60	RadPathResultVal T194 Others
R48	ResultOfTest Desc:T194 Test:T191	
T195	Symptom 1943 1947	mass
A61	IsPresentOnFirstCancerDiagnosis T195 yes
A62	IsCausedByDiagnosedCancer T195 unclear
A63	ChronicVal T195 chronic
A64	ContinuityVal T195 stable
T196	Symptom 1888 1892	pain
A65	NegationModalityVal T196 negated
T197	Site 1883 1887	bone
R49	SiteOf Arg1:T197 Arg2:T196	
T198	ClinicalCondition 2050 2063	Breast cancer
T199	ClinicalCondition 2069 2086	Diabetes mellitus
A66	ChronicVal T199 chronic
T200	PatientCharacteristics 2325 2329	G7P6
A67	SectionSkipType T4 medications
T201	LivingCondition 3432 3467	Lives in ***** with husband and son
A68	IsStoppedOrContinuing T201 continuing
T202	Employment 3684 3697	does not work
T203	Employment 3713 3731	cleaning buildings
A69	ExperiencerVal T203 family
T204	LivingCondition 3604 3619	living in *****
A70	ExperiencerVal T204 family
T205	Duration 3624 3632	33 years
R50	HappensOverlapping Arg1:T204 Arg2:T205	
T206	LivingCondition 3540 3553	live in *****
A71	ExperiencerVal T206 family
T207	LivingCondition 3501 3509	in *****
A72	ExperiencerVal T207 family
T208	LivingCondition 3519 3526	n *****
A73	ExperiencerVal T208 family
T209	LivingCondition 3561 3577	moved from *****
A74	IsStoppedOrContinuing T209 stopped
T210	Datetime 3578 3588	1 year ago
R51	EndsOnOrAt Arg1:T209 Arg2:T210	
T211	LivingCondition 3640 3655	coming to *****
A75	ExperiencerVal T211 family
T212	Datetime 3656 3666	1 year ago
R52	BeginsOnOrAt Arg1:T211 Arg2:T212	
T213	SectionSkip 3854 3923;3926 4629	PHYSICAL EXAM:  General appearance - alert, well appearing, and in no distress  HEENT: anicteric, OP clear  Mental status - alert, oriented to person, place, and time  Lymph nodes - no palpable cervical or supraclavicular lymphadenopathy   Axilla - multiple right axillary nodes, largest 2.5 cm and mobile  Breasts - 7x5 cm mass in RUOQ, mobile, inverted right nipple, left breast without dominant mass   Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm  Abdomen - soft,ND/NT, no HSM  Neurological - A&Ox3, grossly non-focal  Musculoskeletal - No point tenderness in spine or other ***** tenderness  Extremities - no edema  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
A76	SectionSkipType T213 physical_exam
T214	Age 4724 4726	53
T215	Radiology 4846 4852	PET CT
A77	IntentVal T215 staging
T216	BiomarkerName 4760 4762	HR
A78	HistoryVal T216 new
A79	EpisodeDescription T216 FirstOccurrence
T217	ClinicalCondition 4778 4791	breast cancer
A80	ContinuityVal T217 new
T218	BiomarkerName 4772 4776	HER2
A81	HistoryVal T218 new
A82	EpisodeDescription T218 FirstOccurrence
T219	BiomarkerResult 4763 4771	negative
A83	HistoryVal T219 new
A84	EpisodeDescription T219 FirstOccurrence
A85	BiomarkerResultVal T219 Negative
T220	BiomarkerResult 4776 4777	+
A86	HistoryVal T220 new
A87	EpisodeDescription T220 FirstOccurrence
A88	BiomarkerResultVal T220 Positive
R53	BiomarkerRel Arg1:T220 Arg2:T218	
R54	BiomarkerRel Arg1:T216 Arg2:T219	
R55	TumorDesc TumorDetails:T217 Desc:T218	
R56	TumorDesc TumorDetails:T217 Desc:T216	
T221	Metastasis 4876 4886	metastasis
A89	NegationModalityVal T221 uncertain_in_present
T222	Site 4871 4875	bone
R57	SiteOf Arg1:T222 Arg2:T221	
R58	TestOrProcedureReveals Test:T215 Desc:T221	
T223	Radiology 4933 4936	MRI
A90	IntentVal T223 staging
T224	Site 4940 4946	pelvis
T225	Pathology 4951 4957	biopsy
A91	IntentVal T225 staging
R59	SiteOf Arg1:T224 Arg2:T223	
T226	Stage 4979 4981	IV
A92	NegationModalityVal T226 uncertain_in_present
A93	HistoryVal T226 new
A94	EpisodeDescription T226 FirstOccurrence
T227	TreatmentType 4808 4824	systemic therapy
A95	NegationModalityVal T227 hypothetical_in_future
A96	TreatmentIntentVal T227 curative
T228	Stage 5003 5005	IV
A97	NegationModalityVal T228 uncertain_in_present
A98	HistoryVal T228 new
A99	EpisodeDescription T228 FirstOccurrence
T229	MedicationName 5049 5059	paclitaxel
A100	NegationModalityVal T229 hypothetical_in_future
A101	TreatmentIntentVal T229 curative
A102	TreatmentCategory T229 AntiNeoPlastics
T230	Frequency 5042 5048	weekly
T231	MedicationName 5066 5077	trastuzumab
A103	NegationModalityVal T231 hypothetical_in_future
A104	TreatmentIntentVal T231 curative
A105	TreatmentCategory T231 AntiNeoPlastics
T232	MedicationName 5084 5094	pertuzumab
A106	NegationModalityVal T232 hypothetical_in_future
A107	TreatmentIntentVal T232 curative
A108	TreatmentCategory T232 AntiNeoPlastics
T233	Frequency 5079 5083	q3wk
T234	Frequency 5061 5065	q3wk
R60	Temporal Arg1:T229 Arg2:T230	
R61	Temporal Arg1:T231 Arg2:T234	
R62	Temporal Arg1:T232 Arg2:T233	
T235	BiomarkerName 5102 5104	HR
A109	HistoryVal T235 new
A110	EpisodeDescription T235 FirstOccurrence
T236	BiomarkerName 5114 5118	HER2
A111	HistoryVal T236 new
A112	EpisodeDescription T236 FirstOccurrence
T237	BiomarkerResult 5105 5113	negative
A113	HistoryVal T237 new
A114	EpisodeDescription T237 FirstOccurrence
A115	BiomarkerResultVal T237 Negative
T238	BiomarkerResult 5118 5119	+
A116	HistoryVal T238 new
A117	EpisodeDescription T238 FirstOccurrence
A118	BiomarkerResultVal T238 Positive
R63	BiomarkerRel Arg1:T237 Arg2:T235	
R64	BiomarkerRel Arg1:T236 Arg2:T238	
T239	TreatmentType 5249 5256	radiate
A119	NegationModalityVal T239 hypothetical_in_future
T240	Site 5257 5269	bone lesions
R65	SiteOf Arg1:T240 Arg2:T239	
T241	Radiology 5290 5293	MRI
A120	NegationModalityVal T241 planned_in_future
A121	IntentVal T241 staging
T242	Radiology 5302 5305	MRI
A122	NegationModalityVal T242 planned_in_future
A123	IntentVal T242 staging
T243	Site 5294 5300	Pelvis
T244	Site 5306 5310	neck
R66	SiteOf Arg1:T243 Arg2:T241	
R67	SiteOf Arg1:T244 Arg2:T242	
T245	Radiology 5424 5438	echocardiogram
A124	IntentVal T245 treatment-others
T246	MedicationName 5368 5378	paclitaxel
A125	NegationModalityVal T246 planned_in_future
A126	TreatmentContinuityVal T246 planned
A127	TreatmentIntentVal T246 curative
A128	TreatmentCategory T246 AntiNeoPlastics
T247	MedicationName 5385 5396	trastuzumab
A129	NegationModalityVal T247 planned_in_future
A130	TreatmentIntentVal T247 curative
A131	TreatmentCategory T247 AntiNeoPlastics
T248	MedicationName 5403 5413	pertuzumab
A132	NegationModalityVal T248 planned_in_future
A133	TreatmentContinuityVal T248 planned
A134	TreatmentIntentVal T248 curative
A135	TreatmentCategory T248 AntiNeoPlastics
T249	Frequency 5361 5367	weekly
T250	Frequency 5380 5384	q3wk
T251	Frequency 5398 5402	q3wk
R68	Temporal Arg1:T249 Arg2:T246	
R69	Temporal Arg1:T250 Arg2:T247	
R70	Temporal Arg1:T251 Arg2:T248	
R71	SizeOf Arg1:T177 Arg2:T174	
R72	SizeOf Arg1:T178 Arg2:T174	
R73	TestOrProcedureReveals Test:T171 Desc:T177	
R74	TestOrProcedureReveals Test:T171 Desc:T178	
T16	Grade 498 499	2
R75	TestOrProcedureReveals Test:T149 Desc:T16	
R76	HappensAtOnDuring Arg1:T148 Arg2:T164	
R77	HappensAtOnDuring Arg1:T170 Arg2:T171	
T252	Size 865 877	3.5 x 1.7 cm
R78	SizeOf Arg1:T252 Arg2:T179	
T253	PatientCharacteristics 2289 2303	Perimenopausal
T254	PatientCharacteristics 2331 2345	first delivery
T255	Age 2351 2353	17
R79	HappensAtOnDuring Arg1:T254 Arg2:T255	
T256	PatientCharacteristics 3332 3334;3343 3363	FA and wife are related
A136	NegationModalityVal T202 negated
T257	Symptom 5226 5237	bone lesion
A137	NegationModalityVal T257 negated
T258	PatientCharacteristics 2305 2308	LMP
T259	Datetime 2309 2323	1-2 months ago
R80	HappensAtOnDuring Arg1:T258 Arg2:T259	
T260	TreatmentType 2358 2361	HRT
A138	NegationModalityVal T260 negated
T184	RadPathResult 920 959	Solitary small focus of hypermetabolism
A139	RadPathResultVal T184 Unclear
T261	Site 968 973	ilium
T262	Laterality 963 967	left
R38	LateralityOfSite Arg1:T262 Arg2:T261	
R81	SiteOf Arg1:T261 Arg2:T184	
R82	ResultOfTest Desc:T184 Test:T182	
T263	RadPathResult 1056 1060	mass
T264	Site 1049 1055	breast
T265	Laterality 1043 1048	Right
R83	LateralityOfSite Arg1:T265 Arg2:T264	
R84	SiteOf Arg1:T264 Arg2:T263	
R85	ResultOfTest Desc:T263 Test:T182	
T266	LymphNodeInvolvement 1158 1169	lymph nodes
A140	HistoryVal T266 new
A141	EpisodeDescription T266 FirstOccurrence
T267	Site 1146 1157	subpectoral
T268	Site 1133 1141	axillary
T269	Laterality 1127 1132	right
R86	LateralityOfSite Arg1:T269 Arg2:T268	
R87	LateralityOfSite Arg1:T269 Arg2:T267	
R88	SiteOf Arg1:T268 Arg2:T266	
R89	SiteOf Arg1:T267 Arg2:T266	
R90	TestOrProcedureReveals Test:T182 Desc:T266	
T270	RadPathResult 1223 1272	hyperattenuating and mildly hypermetabolic lesion
T271	Site 1294 1320	carotid artery bifurcation
T272	Laterality 1289 1293	left
T273	Size 1210 1222	3.4 x 2.6 cm
A142	RadPathResultVal T270 Unclear
A143	RadPathResultVal T263 InitialCancerDiagnosis
R91	SizeOf Arg1:T273 Arg2:T270	
R92	LateralityOfSite Arg1:T272 Arg2:T271	
R93	SiteOf Arg1:T271 Arg2:T270	
R94	ResultOfTest Desc:T270 Test:T182	
T190	RadPathResult 1392 1444	3 rounded foci of signal abnormality and enhancement
T274	Site 1464 1474	iliac bone
T275	Laterality 1459 1463	left
T276	Site 1489 1499	sacral ala
T277	Laterality 1479 1488	bilateral
R45	LateralityOfSite Arg1:T275 Arg2:T274	
R95	LateralityOfSite Arg1:T277 Arg2:T276	
T278	Size 1517 1522	12 mm
R96	SiteOf Arg1:T274 Arg2:T190	
R97	SiteOf Arg1:T276 Arg2:T190	
R98	SizeOf Arg1:T278 Arg2:T190	
R99	ResultOfTest Desc:T190 Test:T186	
T279	ClinicalCondition 3320 3330	malignancy
A144	NegationModalityVal T279 negated
A145	ExperiencerVal T279 family
T280	Age 3477 3478	.
A146	NegationModalityVal T245 planned_in_future
T281	ap_end 5874 5881	record.
T282	ap_start 4687 4697	ASSESSMENT
A147	SectionSkipType T14 laboratory
T13	hpi_end 1970 1977	stable.
T15	hpi_start 0 5	*****
